Reviews citing this publication (3)
- Site-Specific Proteasome Inhibitors. Kisselev AF. Biomolecules 12 54 (2021)
- A Nut for Every Bolt: Subunit-Selective Inhibitors of the Immunoproteasome and Their Therapeutic Potential. Huber EM, Groll M. Cells 10 1929 (2021)
- Covalent-reversible peptide-based protease inhibitors. Design, synthesis, and clinical success stories. Feral A, Martin AR, Desfoux A, Amblard M, Vezenkov LL. Amino Acids 55 1775-1800 (2023)
Articles citing this publication (19)
- A Set of Activity-Based Probes to Visualize Human (Immuno)proteasome Activities. de Bruin G, Xin BT, Kraus M, van der Stelt M, van der Marel GA, Kisselev AF, Driessen C, Florea BI, Overkleeft HS. Angew Chem Int Ed Engl 55 4199-4203 (2016)
- A unified mechanism for proteolysis and autocatalytic activation in the 20S proteasome. Huber EM, Heinemeyer W, Li X, Arendt CS, Hochstrasser M, Groll M. Nat Commun 7 10900 (2016)
- Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice. Sula Karreci E, Fan H, Uehara M, Mihali AB, Singh PK, Kurdi AT, Solhjou Z, Riella LV, Ghobrial I, Laragione T, Routray S, Assaker JP, Wang R, Sukenick G, Shi L, Barrat FJ, Nathan CF, Lin G, Azzi J. Proc Natl Acad Sci U S A 113 E8425-E8432 (2016)
- A humanized yeast proteasome identifies unique binding modes of inhibitors for the immunosubunit β5i. Huber EM, Heinemeyer W, de Bruin G, Overkleeft HS, Groll M. EMBO J 35 2602-2613 (2016)
- 20S Proteasome as a Drug Target in Trichomonas vaginalis. O'Donoghue AJ, Bibo-Verdugo B, Miyamoto Y, Wang SC, Yang JZ, Zuill DE, Matsuka S, Jiang Z, Almaliti J, Caffrey CR, Gerwick WH, Eckmann L. Antimicrob Agents Chemother 63 e00448-19 (2019)
- Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation. Huang RZ, Liang GB, Huang XC, Zhang B, Zhou MM, Liao ZX, Wang HS. Eur J Med Chem 138 979-992 (2017)
- Roseltide rT7 is a disulfide-rich, anionic, and cell-penetrating peptide that inhibits proteasomal degradation. Kam A, Loo S, Fan JS, Sze SK, Yang D, Tam JP. J Biol Chem 294 19604-19615 (2019)
- Structural Basis for the Species-Selective Binding of N,C-Capped Dipeptides to the Mycobacterium tuberculosis Proteasome. Hsu HC, Singh PK, Fan H, Wang R, Sukenick G, Nathan C, Lin G, Li H. Biochemistry 56 324-333 (2017)
- Competitive Metabolite Profiling of Natural Products Reveals Subunit Specific Inhibitors of the 20S Proteasome. Pawar A, Basler M, Goebel H, Alvarez Salinas GO, Groettrup M, Böttcher T. ACS Cent Sci 6 241-246 (2020)
- Structure-Based Design of Inhibitors Selective for Human Proteasome β2c or β2i Subunits. Xin BT, Huber EM, de Bruin G, Heinemeyer W, Maurits E, Espinal C, Du Y, Janssens M, Weyburne ES, Kisselev AF, Florea BI, Driessen C, van der Marel GA, Groll M, Overkleeft HS. J Med Chem 62 1626-1642 (2019)
- The Architecture of the Anbu Complex Reflects an Evolutionary Intermediate at the Origin of the Proteasome System. Fuchs ACD, Alva V, Maldoner L, Albrecht R, Hartmann MD, Martin J. Structure 25 834-845.e5 (2017)
- Total synthesis and absolute stereochemistry of the proteasome inhibitors cystargolides A and B. Tello-Aburto R, Hallada LP, Niroula D, Rogelj S. Org Biomol Chem 13 10127-10130 (2015)
- Noncytotoxic Inhibition of the Immunoproteasome Regulates Human Immune Cells In Vitro and Suppresses Cutaneous Inflammation in the Mouse. Ah Kioon MD, Pierides M, Pannellini T, Lin G, Nathan CF, Barrat FJ. J Immunol 206 1631-1641 (2021)
- Yeast PI31 inhibits the proteasome by a direct multisite mechanism. Rawson S, Walsh RM, Velez B, Schnell HM, Jiao F, Blickling M, Ang J, Bhanu MK, Huang L, Hanna J. Nat Struct Mol Biol 29 791-800 (2022)
- Cell-Based Optimization of Covalent Reversible Ketoamide Inhibitors Bridging the Unprimed to the Primed Site of the Proteasome β5 Subunit. Stubba D, Bensinger D, Steinbacher J, Proskurjakov L, Salcedo Gómez Á, Schmidt U, Roth S, Schmitz K, Schmidt B. ChemMedChem 14 2005-2022 (2019)
- Design, synthesis, and evaluation of cystargolide-based β-lactones as potent proteasome inhibitors. Niroula D, Hallada LP, Le Chapelain C, Ganegamage SK, Dotson D, Rogelj S, Groll M, Tello-Aburto R. Eur J Med Chem 157 962-977 (2018)
- Synthesis and Biochemical Evaluation of Warhead-Decorated Psoralens as (Immuno)Proteasome Inhibitors. Schiffrer ES, Proj M, Gobec M, Rejc L, Šterman A, Mravljak J, Gobec S, Sosič I. Molecules 26 E356 (2021)
- Brain-Derived 11S Regulator (PA28αβ) Promotes Proteasomal Hydrolysis of Elongated Oligoglutamine-Containing Peptides. Kriachkov VA, Gotmanova NN, Tashlitsky VN, Bacheva AV. Int J Mol Sci 24 13275 (2023)
- Rational design of proteasome inhibitors based on the structure of the endogenous inhibitor PI31/Fub1. Velez B, Razi A, Hubbard RD, Walsh R, Rawson S, Tian G, Finley D, Hanna J. Proc Natl Acad Sci U S A 120 e2308417120 (2023)